EU Countries Agree to Admit Travelers Vaccinated With WHO-Approved Shots

By Reuters
February 24, 2022COVID-19
EU Countries Agree to Admit Travelers Vaccinated With WHO-Approved Shots
European Union flags fly outside the European Commission headquarters in Brussels, on April 10, 2019. (Yves Herman/Reuters)

BRUSSELS—European Union countries agreed on Tuesday to open their borders to travelers from outside the bloc who have had shots against COVID-19 authorized by the World Health Organization (WHO), easing restrictions on those who received Indian and Chinese vaccines.

The EU has so far authorized vaccines produced by Pfizer-BionTech, Moderna, AstraZeneca (when produced in Europe), Johnson & Johnson, and Novavax.

In addition to these shots, the WHO has also approved the vaccines produced by Chinese makers Sinopharm and Sinovac and by Indian company Bharat Biotech. It has also authorized the AstraZeneca vaccine made in India by the Serum Institute.

Until now, most EU countries have not admitted people from outside the bloc traveling for non-essential reasons if they have been vaccinated with shots not approved in the EU.

“Member states should lift the temporary restriction on non-essential travel to the EU for persons vaccinated with an EU- or WHO-approved vaccine,” said a recommendation adopted on Tuesday by EU governments which would be applicable from March 1.

Restrictions will be lifted for travelers who received the final dose of the primary vaccination cycle at least 14 days and no more than 270 days before arrival. Boosted travelers will also be accepted.

EU states also agreed to lift a temporary restriction on non-essential travel for people who have recovered from COVID-19 within 180 days prior to traveling to the EU.

For people inoculated with a WHO-approved vaccine, EU states could also require a negative PCR test taken at the earliest 72 hours before departure and could apply additional measures such as quarantine or isolation.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.